title: Therapeutic continuity in Alzheimer's disease: switching patients to galantamine. Panel discussion: recommendations for prescribers.
authors.affiliation: Department of Neurology, Washington University, St. Louis, Missouri, USA.
authors.forename: J C
authors.initials: JC
authors.lastname: Morris
authors.forename: M R
authors.initials: MR
authors.lastname: Farlow
authors.forename: S H
authors.initials: SH
authors.lastname: Ferris
authors.forename: A F
authors.initials: AF
authors.lastname: Kurz
authors.forename: A
authors.initials: A
authors.lastname: Maelicke
authors.forename: L
authors.initials: L
authors.lastname: Rasmusen
authors.forename: D
authors.initials: D
authors.lastname: Wilkinson
authors.forename: B
authors.initials: B
authors.lastname: Yan
mesh_terms: D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use*; D005702:Galantamine / Q000627:therapeutic use*; D006801:Humans
chemical_list: D002800:Cholinesterase Inhibitors; D005702:Galantamine